Building onto previous years’ panels themes “M&A as tool to scale” and “Opportunities for large investors”, the focus is now on strategies and funding approaches with 3 companies that have achieved scale. In particular, they discussed about pros and cons of staying private vs going public, M&A as way to accelerate growth, and what the next level challenges are once digital health companies grow beyond unicorn status and 500+ employees.
